We are a preclinical stage pharmaceutical company organized as a Nevada corporation in July 2017 to focus on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.
$4.00 - $5.00
November 8, 2019
THE BENCHMARK COMPANY, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for CNS Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277